DTIL

Precision Biosciences Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 2/10
  • Value 0/10
Precision Biosciences sales and earnings growth
DTIL Growth
Fair
  • Revenue Y/Y -50.12%
  • EPS Y/Y -439.05%
  • FCF Y/Y -12.33%
Precision Biosciences gross and profit margin trends
DTIL Profitability
Low
  • Gross margin 100.00%
  • EPS margin -133.40%
  • ROIC 5Y 0.00%
Precision Biosciences net debt vs free cash flow
DTIL Risk
Great
  • Debt / Equity 0.3
  • Debt / FCF 0.0
  • Interest coverage -31.1

Precision Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗